Finch Therapeutics Valuation
| FNCH Stock | USD 12.80 0.20 1.54% |
At this time, the firm appears to be overvalued. Finch Therapeutics shows a prevailing Real Value of $10.76 per share. The current price of the firm is $12.8. Our model computes the value of Finch Therapeutics from reviewing the firm fundamentals such as Current Valuation of 10.74 M, shares owned by institutions of 11.35 %, and Shares Owned By Insiders of 53.48 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Finch Therapeutics' price fluctuation is not too volatile at this time. Calculation of the real value of Finch Therapeutics is based on 3 months time horizon. Increasing Finch Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Finch Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Finch Pink Sheet. However, Finch Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.8 | Real 10.76 | Hype 13.0 | Naive 12.8 |
The intrinsic value of Finch Therapeutics' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Finch Therapeutics' stock price.
Estimating the potential upside or downside of Finch Therapeutics Group helps investors to forecast how Finch pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Finch Therapeutics more accurately as focusing exclusively on Finch Therapeutics' fundamentals will not take into account other important factors: About Finch Therapeutics Valuation
An absolute valuation paradigm, as applied to Finch Pink Sheet, attempts to find the value of Finch Therapeutics based on its fundamental and basic technical indicators. By analyzing Finch Therapeutics's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Finch Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Finch Therapeutics. We calculate exposure to Finch Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Finch Therapeutics's related companies.Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts. Finch Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 189 people.
8 Steps to conduct Finch Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Finch Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Finch Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Finch Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Finch Therapeutics' revenue streams: Identify Finch Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Finch Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Finch Therapeutics' growth potential: Evaluate Finch Therapeutics' management, business model, and growth potential.
- Determine Finch Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Finch Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Finch Pink Sheet analysis
When running Finch Therapeutics' price analysis, check to measure Finch Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Finch Therapeutics is operating at the current time. Most of Finch Therapeutics' value examination focuses on studying past and present price action to predict the probability of Finch Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Finch Therapeutics' price. Additionally, you may evaluate how the addition of Finch Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |